Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA.
Blood Cancer J. 2023 Jul 26;13(1):113. doi: 10.1038/s41408-023-00885-9.
Blood Cancer J. 2023.
PMID: 37495597
Free PMC article.
No abstract available.